Nathan Jorgensen, Ph D.

Nathan Jorgensen, Ph D.

Chief Financial OfficeratVoyager Therapeutics· In proxies 2023–2024

Pay in FY2024Voyager Therapeutics stock -32.8% the same year

Nathan Jorgensen, Ph D. was paid $1.9M in FY2024 (Dec). Voyager Therapeutics stock fell 32.8% that year.

Pay$100 in the stock at the end of FY22 → $93
Pay is from the Summary Compensation Table of each Voyager Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Voyager TherapeuticsPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role -66%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?